Skip to content

Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.

Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer. - Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057775
Enrollment
400
Registered
2025-06-01
Start date
2010-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

None listed

Sponsors

Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing transurethral cystectomy for bladder cancer

Exclusion criteria

Exclusion criteria: Patients who have expressed their refusal to participate in this study through a release of information document

Design outcomes

Primary

MeasureTime frame
Comparison of histopathological diagnosis and prognosis of specimens obtained by transurethral surgery (conventional and en bloc resection) for bladder cancer.

Countries

Japan

Contacts

Public ContactYOHEI OKADA

Saitama Medical Center, Saitama Medical University Department of Urology

okada@saitama-med.ac.jp049-228-3673

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026